We measured lumbar spine, hip (total and sub-regions) and total body b
one mineral densities (BMDs) by dual-energy X-ray absorptiometry (DXA)
in 47 premenopausal female patients suffering from systemic lupus ery
thematosus (SLE). As compared to healthy controls, SLE patients had lo
wer BMDs at all trabecular and cortical sites. Comparison of BMDs betw
een patients ever and never treated with glucocorticoids indicated tha
t patients who had ever received glucocorticoids had a significantly l
ower lumbar spine BMD compared to those who never did. Moreover, bone
loss in patients ever treated with glucocorticoids was commensurate wi
th their cumulated oral glucocorticoid intake. Interestingly, patients
never treated with glucocorticoids had a lower hip BMD compared to co
ntrols, thereby suggesting that the disease per se might induce some b
one loss. Taken together, SLE patients suffer from a significant trabe
cular and cortical bone loss indicative of an increased risk of future
fracture.